APT Medical Inc
SSE:688617
US |
Fubotv Inc
NYSE:FUBO
|
Media
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
US |
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
|
CN |
NIO Inc
NYSE:NIO
|
Automobiles
|
|
US |
Fluor Corp
NYSE:FLR
|
Construction
|
|
US |
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
|
US |
TopBuild Corp
NYSE:BLD
|
Consumer products
|
|
US |
Abbott Laboratories
NYSE:ABT
|
Health Care
|
|
US |
Chevron Corp
NYSE:CVX
|
Energy
|
|
US |
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
|
US |
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
|
US |
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
|
US |
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
|
US |
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
231.673
439
|
Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
Fubotv Inc
NYSE:FUBO
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
C
|
C3.ai Inc
NYSE:AI
|
US |
Uber Technologies Inc
NYSE:UBER
|
US | |
NIO Inc
NYSE:NIO
|
CN | |
Fluor Corp
NYSE:FLR
|
US | |
Jacobs Engineering Group Inc
NYSE:J
|
US | |
TopBuild Corp
NYSE:BLD
|
US | |
Abbott Laboratories
NYSE:ABT
|
US | |
Chevron Corp
NYSE:CVX
|
US | |
Occidental Petroleum Corp
NYSE:OXY
|
US | |
Matrix Service Co
NASDAQ:MTRX
|
US | |
Automatic Data Processing Inc
NASDAQ:ADP
|
US | |
Qualcomm Inc
NASDAQ:QCOM
|
US | |
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one APT Medical Inc stock under the Base Case scenario is 329.82 CNY. Compared to the current market price of 349.23 CNY, APT Medical Inc is Overvalued by 6%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
APT Medical Inc
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for APT Medical Inc cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Economic Moat
APT Medical Inc
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
APT Medical Inc
Balance Sheet Decomposition
APT Medical Inc
Current Assets | 1.5B |
Cash & Short-Term Investments | 1B |
Receivables | 61.2m |
Other Current Assets | 401.2m |
Non-Current Assets | 1.3B |
Long-Term Investments | 176.8m |
PP&E | 534.1m |
Intangibles | 128.3m |
Other Non-Current Assets | 430m |
Current Liabilities | 541.4m |
Accounts Payable | 55.4m |
Accrued Liabilities | 107.3m |
Other Current Liabilities | 378.7m |
Non-Current Liabilities | 69m |
Long-Term Debt | 4.5m |
Other Non-Current Liabilities | 64.5m |
Earnings Waterfall
APT Medical Inc
Revenue
|
1.9B
CNY
|
Cost of Revenue
|
-546.2m
CNY
|
Gross Profit
|
1.3B
CNY
|
Operating Expenses
|
-650.6m
CNY
|
Operating Income
|
666.4m
CNY
|
Other Expenses
|
-47.3m
CNY
|
Net Income
|
619.1m
CNY
|
Free Cash Flow Analysis
APT Medical Inc
CNY | |
Free Cash Flow | CNY |
Profitability Score
Profitability Due Diligence
APT Medical Inc's profitability score is 75/100. The higher the profitability score, the more profitable the company is.
Score
APT Medical Inc's profitability score is 75/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
APT Medical Inc's solvency score is 85/100. The higher the solvency score, the more solvent the company is.
Score
APT Medical Inc's solvency score is 85/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
APT Medical Inc
According to Wall Street analysts, the average 1-year price target for APT Medical Inc is 383.45 CNY with a low forecast of 316.23 CNY and a high forecast of 477.75 CNY.
Dividends
Current shareholder yield for APT Medical Inc is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
APT Medical, Inc. engages in the research, development, production, and sale of electrophysiology, coronary access, and peripheral vascular intervention medical devices. The company is headquartered in Shenzhen, Guangdong and currently employs 1,511 full-time employees. The company went IPO on 2021-01-07. The firm's electrophysiological products include electrophysiological electrode catheters, controllable radiofrequency ablation electrode catheters and multichannel electrophysiological systems. Its coronary artery access products mainly include guide wires, micro catheters, balloons, contrast guide wires and catheters. The firm's peripheral vascular intervention products are mainly applied in peripheral vascular diseases. The firm is also engaged in related original equipment manufacturer (OEM) business. The firm distributes its products within domestic market and to overseas markets.
Contact
IPO
Employees
Officers
The intrinsic value of one APT Medical Inc stock under the Base Case scenario is 329.82 CNY.
Compared to the current market price of 349.23 CNY, APT Medical Inc is Overvalued by 6%.